Vaxil Bio Ltd (VXL)
TSXV
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | -4.55M | -1.8M | -1.04M | -939k | -862k | -660k | -394k | -259k |
Pre Tax Income | -4.54M | -1.8M | -1.05M | -1.15M | -1.36M | -986k | -584k | -254k |
Net Income | -4.54M | -1.8M | -1.05M | -1.15M | -1.36M | -986k | -584k | -254k |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -0.095 | -0.036 | -0.012 | -0.013 | -0.011 | -0.007 | -0.004 | -0.002 |
EBIT | -4.55M | -1.8M | -1.04M | -939k | -862k | -660k | -394k | -259k |
EBITDA | -4.55M | -1.8M | -985k | -839k | -805k | -635k | -392k | -259k |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.